M.A. Ritter

584 total citations
28 papers, 447 citations indexed

About

M.A. Ritter is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M.A. Ritter has authored 28 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 14 papers in Radiation and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M.A. Ritter's work include Advanced Radiotherapy Techniques (14 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Prostate Cancer Treatment and Research (10 papers). M.A. Ritter is often cited by papers focused on Advanced Radiotherapy Techniques (14 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Prostate Cancer Treatment and Research (10 papers). M.A. Ritter collaborates with scholars based in United States, Canada and Germany. M.A. Ritter's co-authors include Richard J. Chappell, Wolfgang A. Tomé, Edward M. Messing, Sarah‐Jane Potts, Thomas G. Shanahan, T. Kinsella, Paul M. Harari, Theodore S. Hong, E. Gregory MacEwen and David M. Vail and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Applied Physics.

In The Last Decade

M.A. Ritter

27 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.A. Ritter United States	10	341	146	70	48	46	28	447
Karin Lindberg Sweden	11	260 0.8×	156 1.1×	114 1.6×	25 0.5×	8 0.2×	27	425
Sanford Katz United States	12	170 0.5×	79 0.5×	57 0.8×	43 0.9×	10 0.2×	25	365
Mélissa Thomas Belgium	14	154 0.5×	76 0.5×	78 1.1×	9 0.2×	13 0.3×	26	430
Tiffany Martin United States	7	86 0.3×	19 0.1×	11 0.2×	38 0.8×	13 0.3×	27	194
Anika Jahnke Germany	9	190 0.6×	246 1.7×	169 2.4×	33 0.7×	2 0.0×	17	475
Barry B. Hobbs Canada	8	66 0.2×	31 0.2×	190 2.7×	20 0.4×	5 0.1×	14	428
K. Kian Ang United States	8	90 0.3×	37 0.3×	25 0.4×	4 0.1×	39 0.8×	10	408
Keijiro Shiomitsu United States	10	225 0.7×	12 0.1×	12 0.2×	70 1.5×	10 0.2×	32	335
Mark Arends United Kingdom	5	75 0.2×	97 0.7×	177 2.5×	10 0.2×	2 0.0×	6	519
Takuo Shida Japan	10	113 0.3×	16 0.1×	29 0.4×	31 0.6×	2 0.0×	37	258

Countries citing papers authored by M.A. Ritter

Since Specialization

Citations

This map shows the geographic impact of M.A. Ritter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Ritter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Ritter more than expected).

Fields of papers citing papers by M.A. Ritter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Ritter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Ritter. The network helps show where M.A. Ritter may publish in the future.

Co-authorship network of co-authors of M.A. Ritter

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Ritter. A scholar is included among the top collaborators of M.A. Ritter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Ritter. M.A. Ritter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morris, Zachary S., et al.. (2017). A Phase 1/2 Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With a Simultaneous Integrated Boost to MRI-Identified Regions of High Tumor Volume (NCT02470897). International Journal of Radiation Oncology*Biology*Physics. 99(2). E255–E255. 1 indexed citations

Johnson, Skyler B., Pamela R. Soulos, Timothy D. Shafman, et al.. (2016). Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). E242–E242. 1 indexed citations

Summerfield, Douglas T., et al.. (2013). Fat embolism syndrome: improved diagnosis through the use of bedside echocardiography. SHILAP Revista de lepidopterología. 7(4). 255–264. 2 indexed citations

Mohindra, Pranshu, Robert J. Rettammel, M.A. Ritter, & Sharon M. Weber. (2013). Impact of Neoadjuvant Therapy on Peri-Operative Morbidity and Mortality After Pancreaticoduodenectomy for Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 87(2). S87–S87.

Cross, Deanna, M.A. Ritter, & Douglas J. Reding. (2012). Historical Prostate Cancer Screening and Treatment Outcomes from a Single Institution. Clinical Medicine & Research. 10(3). 97–105. 4 indexed citations

Ritter, M.A., Jeffrey D. Forman, Patrick A. Kupelian, et al.. (2011). Five-year Efficacy and Toxicity Outcomes from a Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 81(2). S99–S99. 5 indexed citations

Ritter, M.A., Jeffrey D. Forman, Patrick A. Kupelian, et al.. (2009). A Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 75(3). S80–S81. 8 indexed citations

Schubert, Lenhart K., Karl Rasmussen, D Westerly, et al.. (2008). SU‐GG‐J‐79: Effect of Body Weight On Patient Setup for Prostate Helical Tomotherapy Treatments. Medical Physics. 35(6Part6). 2697–2697. 1 indexed citations

Adkison, Jarrod B., et al.. (2008). Pelvic Nodal Dose Escalation in Conjunction with Hypofractionated IMRT for High Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 72(1). S305–S305. 1 indexed citations

10.

Mehta, Minesh P., Judith S. Kaur, C. Norman Coleman, et al.. (2006). 1014. International Journal of Radiation Oncology*Biology*Physics. 66(3). S136–S137. 1 indexed citations

11.

Hong, Theodore S., M.A. Ritter, Wolfgang A. Tomé, & Paul M. Harari. (2005). Intensity-modulated radiation therapy: emerging cancer treatment technology. British Journal of Cancer. 92(10). 1819–1824. 67 indexed citations

12.

Hong, Theodore S., et al.. (2005). Pelvic Nodal Dose Escalation with Prostate Hypofractionation Using Conformal Avoidance Defined (H-CAD) Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 63. S61–S62. 1 indexed citations

13.

Aoyama, Hidefumi, D Westerly, T Mackie, et al.. (2005). Integral Radiation Dose to Normal Structures with Conformal External Beam Radiation. International Journal of Radiation Oncology*Biology*Physics. 63. S559–S559. 4 indexed citations

14.

Ritter, M.A., Richard J. Chappell, Wolfgang A. Tomé, & Patrick A. Kupelian. (2005). A Multi-Institutional Phase I/II Trial of Dose-per-fraction Escalation for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 63. S124–S124. 7 indexed citations

15.

Keller, H., Wolfgang A. Tomé, M.A. Ritter, & T Mackie. (2003). Design of adaptive treatment margins for non-negligible measurement uncertainty: application to ultrasound-guided prostate radiation therapy. Physics in Medicine and Biology. 49(1). 69–86. 20 indexed citations

16.

Patel, Rakesh R., Wolfgang A. Tomé, Nigel P. Orton, et al.. (2002). The use of an endorectal balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer: a DVH analysis of rectal dose-sparing with 3D-CRT, IMRT, and helical tomotherapy. International Journal of Radiation Oncology*Biology*Physics. 54(2). 259–259. 2 indexed citations

17.

Vail, David M., William C. Kisseberth, Joyce E. Obradovich, et al.. (1996). Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.. PubMed. 24(7). 807–15. 72 indexed citations

18.

Harari, Paul M., et al.. (1993). Modulation of Proliferation Kinetics in Human Squamous Cell Carcinomas of the Head and Neck. Archives of Otolaryngology - Head and Neck Surgery. 119(7). 738–742. 9 indexed citations

19.

Ritter, M.A., Edward M. Messing, Thomas G. Shanahan, et al.. (1992). Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer.. Journal of Clinical Oncology. 10(8). 1208–1217. 159 indexed citations

20.

Ritter, M.A., C.V. Morr, & R.L. Thomas. (1987). In Vitro Digestibility of Phytate‐Reduced and Phenolics‐Reduced Soy Protein Isolates. Journal of Food Science. 52(2). 325–327. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact